Abrysvo is now approved to prevent lower respiratory tract disease caused by RSV in high-risk adults over 18 years of age.

Health experts are warning of a potential 'tripledemic' this winter - here's how to spot the early symptoms of flu, RSV and ...

The NHS has listed the symptoms of covid, RSV and flu to help you tell the difference between each one, as cases forecast to ...

Merck said on Thursday its experimental antibody therapy, clesrovimab, demonstrated a 60.4% effectiveness in reducing some ...

EDP-323 is an investigational inhibitor of Respiratory Syncytial Virus (RSV), currently showing promising results in Phase 2a ...

Merck is discussing the study data with regulators worldwide, with a goal of making the treatment available for infants as early as the 2025 to 2026 RSV season.

Study explores the clinical manifestations, risk factors, and 90-day mortality outcomes in adults hospitalized with RSV or ...

RSV, or Respiratory Syncytial Virus, is a highly contagious virus that frequently spreads among preschool children, ...

Despite being back in the season of sniffles and sick days, Washington state will be extra equipped to battle the spread of respiratory viruses this year.

Clesrovimab (MK-1654), an Investigational RSV Monoclonal Antibody, Significantly Reduced Incidence of RSV Disease and ...

The Eastern Ontario Health Unit is advising a new treatment is now available in the region to help protect infants from the ...

The NHS has listed the symptoms of covid, RSV and flu to help you tell the difference between each one, as cases forecast to ...